We want to clear up some possible confusion. If a patient has vision loss or blindness after getting Beovu injections in their eyes, this person must contact a lawyer or law firm to handle their Beovu case in order to get legal compensation for the Beovu drug injury they have suffered. That is because Beovu lawsuits are being filed as individual … [Read more...]
Beovu Side Effects and Beovu Lawsuits for Patients Complicate Future for Beovu
Given the serious nature and number of Beovu side effects reported to date, together with the Beovu lawsuits filed against Novartis for patients with severe vision loss, it seems fair to say that things look a bit grim for Beovu and Novartis at the start of 2021. So what does the path forward look like for Beovu? Let’s start with where things … [Read more...]
Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?
As we start 2021, let’s look at where things currently stand with the Beovu “safety issue” — Beovu adverse drug reactions and Beovu-related eye problems — and how we got here. In the 15 months since Beovu was approved by the FDA in October 2019, there have been numerous reports of Beovu causing occlusive retinal vasculitis, retinal artery … [Read more...]
Beovu Retinal Vasculitis Made Worse by a Later Lucentis Treatment
A recent medical journal article presents an interesting case report about a 76-year-old woman with Beovu-related retinal vasculitis which was made worse by a later Lucentis treatment for her wet AMD. That patient's doctors are the authors of "Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A … [Read more...]
Beovu-related Retinal Vasculitis and Beovu Vision Loss Cases
As of December 2020, the investigation continues to find the root causes of Beovu-related retinal vasculitis which seems to be involved in many of the growing numbers of Beovu vision loss cases. At the same time retina specialists and other eye doctors are still trying to determine the best medical management or treatment methods for Beovu patients … [Read more...]
Beovu Legal Cases: Compensation for Eye Problems from Beovu Use
Our law firm is investigating possible Beovu lawsuits for patients who have been diagnosed with vision loss, blindness, or other serious eye problems which are Beovu side effects. Such drug injury Beovu legal cases might involve one or more of the following Beovu eye-related side effects: Vision LossBlindnessOcclusive Retinal VasculitisRetinal … [Read more...]
Beovu Use Continues Despite Ongoing Beovu-associated Inflammation Investigation
A summary of the Beovu-associated inflammation safety issue is presented in this July 2020 Journal of VitreoRetinal Diseases Research Article, “Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab”. From the Abstract for this item we get these details about the current Beovu safety issue under investigation: Conclusions: … [Read more...]
Beovu | July 2020 | Current Findings For Occlusive Vasculitis And Vision Loss
Beovu safety issues were a dominant topic at a recent national meeting of eye doctors. They discussed possible Beovu side effects such as occlusive vasculitis and vision loss following Beovu injections for treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). We get these significant points from this July 26, 2020, Ocular … [Read more...]
Beovu: External Safety Review Committee Findings Lead To New Vision-Related Side Effects Warnings
First, Novartis set up an internal review of Beovu vision-related side effects observed in the HAWK & HARRIER clinical trials, including rare post-marketing safety reports of vasculitis. In turn, new warnings for Beovu eye injections about retinal vasculitis and retinal vascular occlusion were added to the Beovu drug label. We take a closer … [Read more...]
Beovu Vision Loss And Retinal Vasculitis Cases May Lead To New Warnings
There have been reports of severe vision loss associated with Beovu injections as well as cases of vasculitis linked to Beovu. In March 2020 Novartis stated that the current Beovu Prescribing Information document sufficiently addressed Beovu risks of intraocular inflammation and retinal artery occlusion. However, Novartis recently said that … [Read more...]